Fortis Malar Hospitals Ltd - Stock Valuation and Financial Performance

BSE: 523696 | NSE: | Hospital & Healthcare Services | Small Cap

Fortis MalarHospital Share Price

46.90 0.75 1.63%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Fortis MalarHospital

M-Cap below 100cr DeciZen not available

Fortis Malar Hospitals stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
87.3 Cr.
52-wk low:
44
52-wk high:
91.3

Is Fortis Malar Hospitals Ltd an attractive stock to invest in?

1. Is Fortis Malar Hospitals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Fortis Malar Hospitals Ltd is a below average quality company.

2. Is Fortis Malar Hospitals Ltd undervalued or overvalued?

The key valuation ratios of Fortis Malar Hospitals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Fortis Malar Hospitals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Fortis Malar Hospitals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Fortis MalarHospital:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Fortis Malar Hospitals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 11.1%9.2%7.2%3.2%3.4%2.1%-3.6%-8.6%-4.6%-16.1%-
Value Creation
Index
-0.2-0.3-0.5-0.8-0.8-0.9-1.3-1.6-1.3-2.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 10811813014114914511269.286.28674
Sales YoY Gr.-8.8%9.9%8.5%6.1%-3.1%-22.6%-38.1%24.5%-0.3%-
Adj EPS 4.64.13.51.51.71-4.8-6.8-4.5-8.3-8.4
YoY Gr.--10.8%-16%-56.1%10.5%-42.9%-600%NANANA-
BVPS (₹) 45.348.65252.754.455.350.446.241.633.128.3
Adj Net
Profit
8.67.76.42.83.11.8-9-12.8-8.3-15.5-16
Cash Flow from Ops. 5.84.210.7-10.39.8-15.7-0.3-1.26.85.6-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -2.5%-10.4%-8.4%-0.3%
Adj EPS -206.7%-237.6%NANA
BVPS-3.4%-9.5%-13.1%-20.5%
Share Price 7.4% -3.1% -5.5% -3.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
10.78.86.92.93.11.7-9.1-14.2-10.1-22.2-27.4
Op. Profit
Mgn %
8.36.44.20.61.2-1.6-2.4-9.145.3-1.3
Net Profit
Mgn %
7.96.5522.11.2-8-18.5-9.7-18.1-21.3
Debt to
Equity
0000000000-
Working Cap
Days
239252239227247283295372339346182
Cash Conv.
Cycle
-24-26-33-27-32-39-41-49-52-65109

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years -8.41%

Sales growth is not so good in last 4 quarters at -15.52%

Latest Financials - Fortis Malar Hospitals Ltd.

Standalone Consolidated
TTM EPS (₹) -8.4 -8.4
TTM Sales (₹ Cr.) 74.2 74.2
BVPS (₹.) 28.3 29.5
Reserves (₹ Cr.) 34 37
P/BV 1.65 1.58
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 44.00 / 91.33
All Time Low / High (₹) 0.90 / 102.20
Market Cap (₹ Cr.) 87.3
Equity (₹ Cr.) 18.7
Face Value (₹) 10
Industry PE 83.6

Management X-Ray of Fortis MalarHospital:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Fortis MalarHospital

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales108.38117.93129.61140.56149.19144.59111.8769.2486.1885.95
Operating Expenses 99.47110.40124.45139.69147.47147.03114.6175.5782.7381.37
Manufacturing Costs52.1858.1469.2277.5078.5777.5558.0637.4442.0844
Material Costs24.5227.5526.9229.7233.0633.4021.3114.0617.0212.66
Employee Cost 13.9515.4717.5219.7921.5423.1521.4618.1818.5319.33
Other Costs 8.829.2310.7812.6914.2912.9313.795.895.105.38
Operating Profit 8.917.535.160.871.72-2.43-2.74-6.323.454.58
Operating Profit Margin (%) 8.2%6.4%4.0%0.6%1.2%-1.7%-2.4%-9.1%4.0%5.3%
Other Income 6.617.368.587.568.189.6810.928.087.336.56
Interest 0.460.510.400.460.380.517.817.206.566.07
Depreciation 1.992.713.163.944.214.3812.5312.8812.5312.15
Exceptional Items 00-0.5100006.8500
Profit Before Tax 13.0711.679.674.045.312.36-12.16-11.47-8.31-7.08
Tax 4.524.013.451.222.170.62-3.10-3.4508.46
Profit After Tax 8.567.666.232.823.141.74-9.06-8.01-8.31-15.53
PAT Margin (%) 7.9%6.5%4.8%2.0%2.1%1.2%-8.1%-11.6%-9.6%-18.1%
Adjusted EPS (₹)4.64.13.41.51.70.9-4.8-4.3-4.4-8.3
Dividend Payout Ratio (%)11%12%15%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 84.2390.4696.6798.28101.60103.5994.4386.6277.9761.96
Share Capital 18.6118.6118.6218.6818.7018.7618.7618.7618.7618.76
Reserves 65.6271.8578.0579.6082.9084.8475.6767.8659.2143.20
Minority Interest0000000000
Debt0000000000
Long Term Debt0000000000
Short Term Debt0000000000
Trade Payables10.2912.7721.1114.0624.9723.3118.8814.4419.9920.26
Others Liabilities 6.2123.9811.2515.7619.3519.7472.8957.4752.2553.48
Total Liabilities 100.72127.21129.03128.09145.91146.65186.19158.53150.22135.69

Fixed Assets

Gross Block27.3230.3927.6431.6635.0737.32100.42100.7494.0587.74
Accumulated Depreciation9.6912.683.147.0711.2815.4819.3432.2136.4240.33
Net Fixed Assets17.6317.7124.5024.5923.7921.8581.0868.5257.6247.41
CWIP 0.640.640.360.610.720.730.090.360.060
Investments 0.050.050.050.050.050.050.050.050.050.05
Inventories0.2712.612.312.021.651.311.631.861.10
Trade Receivables3.904.216.015.5869.663.732.092.203.18
Cash Equivalents 10.1518.3125.087.4014.686.6441.7211.6010.497.31
Others Assets68.0885.2970.4287.5598.65106.0758.2374.2877.9476.64
Total Assets 100.72127.21129.03128.09145.91146.65186.19158.53150.22135.69

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 5.754.1810.70-10.349.75-15.73-0.27-1.206.805.61
PBT 13.0711.679.674.045.312.36-12.16-11.47-8.31-7.08
Adjustment -3.84-3.88-3.57-2.31-3.25-5.0412.745.5211.8411.71
Changes in Working Capital 0.432.058.66-3.7512.23-8.513.76-6.913.940.88
Tax Paid -3.91-5.65-4.06-8.31-4.53-4.53-4.6111.66-0.680.10
Cash Flow From Investing Activity -1.425.23-2215.18-2.296.1148.31-27.608.180.43
Capex -2.67-3.38-10.57-2.95-3.68-2.70-2.90-0.53-1.28-1.88
Net Investments 00-19.120001.40-5.935.99-3.43
Others 1.248.617.6918.141.398.8149.81-21.143.475.74
Cash Flow From Financing Activity -1.100-1.09-0.970.050.15-11.57-7.25-10.10-12.65
Net Proceeds from Shares 000.030.150.050.150000
Net Proceeds from Borrowing 0000000000
Interest Paid -0.07000000000
Dividend Paid -0.870-0.93-0.93000000
Others -0.160-0.19-0.1900-11.57-7.25-10.10-12.65
Net Cash Flow 3.239.41-12.393.887.51-9.4736.47-36.054.87-6.61
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)10.638.776.662.893.141.69-9.15-8.85-10.09-22.21
ROCE (%)16.8113.9410.774.615.72.8-4.39-4.71-2.12-1.44
Asset Turnover Ratio1.141.031.011.091.090.990.670.40.560.6
PAT to CFO Conversion(x)0.670.551.72-3.673.11-9.04N/AN/AN/AN/A
Working Capital Days
Receivable Days1213141514202215911
Inventory Days1256555876
Payable Days142153230216215264361433369580

Fortis Malar Hospitals Ltd Stock News

Fortis Malar Hospitals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Fortis MalarHospital on 28-Mar-2024 16:01 is ₹46.90.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Fortis MalarHospital stood at ₹87.34.
The latest P/E ratio of Fortis MalarHospital as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of Fortis MalarHospital as of 28-Mar-2024 16:01 is 1.65.
The 52-week high of Fortis MalarHospital is ₹91.33 and the 52-week low is ₹44.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fortis MalarHospital is ₹74.15 ( Cr.) .

About Fortis Malar Hospitals Ltd

Malar Hospitals (an Associate of Fortis Healthcare), like every other Fortis hospital, is a manifestation of the founder’s vision of creating a world-class integrated healthcare delivery system in India, entailing the finest medical skills combined with compassionate patient care.

Malar Hospitals is one of India’s leading multi-specialty hospitals. Founded in 1992 and located in Chennai near the famous Theosophical Society, Adyar. Malar Hospitals is equipped with ultra-modern medical infrastructure that is on par with the best in the world. Among the faculty are renowned consultants with decades of experience and excellence in their fields.Dr.S.Ramamurthy , the chief promoter and  Chairman and Managing Director of Malar Hospitals Ltd is Family consulatant and Sonoligist since 1979. He has been an NRI since 1979 to February 1986. He was a Medical Officer and Consultant in charge of Fudo consortium cilinic owned by Japanease Firm Yanbu at Saudi Arabia 

Malar Hospitals is a leading centre for cardiac care, renal transplants, neurosurgery, oto- laryngocoloy, limb reconstruction surgery and maxillo facial orthodontology. It also has one of South India’s best trauma care centers.

Since the beginning, Malar Hospitals has been serving clients from across India, South East Asia and the Middle East - with the singular objective of providing Humane Care for Human Cure.

The Department of Orthopedic Surgery of Malar Hospitals is a reputed centre for trauma care in India. The orthopedic team offers comprehensive, specialized care for all trauma and cold orthopedic conditions. All out-patients are treated in the orthopedic clinic. Intra- articular injections and needling of trigger spots are performed in the injection clinic as out-patient procedures. In-patient and post-operative patients are seen during the twice-a-day ward rounds. All orthopedic and trauma surgeries are performed in a state-of-the-art exclusive orthopedic operation theatre, which is equipped with an image intensifier, orthopedic fracture table, arthroscopy system, Swiss-made operating instruments and all orthopedic implants and prostheses.

The highly experienced team of anesthesiologists of Malar Hospital can handle any emergency situation or high- risk patient. They have highly experienced operating - theatre staff and technicians who ensure smooth and safe conduct of all surgeries.

Malar Hospital, with 180 beds, focuses on providing comprehensive medical care in the areas of cardiology and cardiac surgery, gynecology, orthopedics, gastroenterology, neurology, pediatrics, diabetics, and nephrology.

Malar Hospitals also has a state of the art Cath Lab and multiple dedicated cardiac operation theatres and intensive coronary care units. Several rare and complex Adult and Pediatric Cardiac surgeries, Orthopedics and Joint replacement, Neurosurgery and Plastic reconstruction surgeries have been performed in this hospital.  The hospital’s Obstetrics and Gynecology services are among the busiest in the city, performing many difficult deliveries and surgeries successfully, and are supported by a dedicated Neonatology unit.

Malar Hospital's Escorts Heart Centre had tied up with Aishwarya Trust to help poor children with congenital heart defect (CHD) as part of the government scheme Ilam Sirar Iruthaya Pathukappu Thittam.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.